Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Study reveals link between self-perceived antibody response and actual COVID-19 protection

Can individuals assess the strength of their antibody response following coronavirus disease 2019?

8 Aug 2023

New antibody shows promise in reversing carfentanil overdoses

An antibody in single-chain fragment variable (scFv) format that binds to the powerful opioid carfentanil was shown to reverse signs of carfentanil overdose in preclinical tests conducted by scientists at Scripps Research.

7 Aug 2023

Adjuvanted intranasal vaccine shows promise for long-lasting immunity to COVID-19

While much of the global concern has subsided, COVID-19 is still a very real threat, especially to people with compromised immune systems or who are over 65.

7 Aug 2023

Understanding variations in SARS-CoV-2 evolution and clearance by immunodeficiency status

Researchers describe the virological range of persistent SARS-CoV-2 infection in immunosuppressed individuals.

7 Aug 2023

People living with HIV respond well to COVID-19 infection and vaccination

Researchers examine the antibody response to natural infection or COVID-19 vaccination in individuals living with HIV infection.

7 Aug 2023

Covid cases and hospital admissions soar, leading testing expert warns of resurgence

A leading testing expert fears the UK is facing a Covid resurgence, as cases and hospital admissions soar. He says the Government must resume the antibody testing program it scrapped in March.

7 Aug 2023

The impact of COVID-19 vaccination and boosters on maternal SARS-CoV-2 infections and birth outcomes

During the COVID-19 pandemic, pregnancy was recognized to be a high-risk condition for adverse outcomes following infection SARS-CoV-2.

4 Aug 2023

Multifunctional Ga-based nanoparticles combine cancer phototherapy with immunotherapy

Researchers develop a novel cancer theranostic agent that can covert light energy to heat and in turn destroy cancer cells

4 Aug 2023

The association of long-term air pollution exposure with SARS-CoV-2 infection

Researchers investigated the association between air quality and risk of SARS-CoV-2 infection.

4 Aug 2023

Cryo-EM structures and functions of potent bispecific antibodies against multiple Omicron sublineages

Researchers characterizes the structures and functions of potent bispecific antibodies against multiple Omicron subvariants using Cryo-EM.

3 Aug 2023

Study finds α5 integrin as a potential therapeutic target in amyotrophic lateral sclerosis

Researchers examined the therapeutic effects of targeting integrins for treating Amyotrophic lateral sclerosis (ALS).

3 Aug 2023

New drug targets EMT in cancer, reducing metastasis and resistance to chemotherapy

Metastases and resistance to chemotherapy are the main causes of treatment failure and mortality in cancer patients.

2 Aug 2023

Identifying risks and solutions: study uncovers correlates of protection against COVID-19

Study identified correlates of protection healthy individuals who have received three doses of Pfizer- BNT162b2 vaccine.

2 Aug 2023

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

In a recent study, researchers working at Ohio State University in the United States of America (USA) developed an intranasal subunit vaccine.

2 Aug 2023

New treatment offers hope for children suffering from rare skin condition

It’s a beautiful moniker, but for Australia’s ‘butterfly children’ it belies a devastating reality filled with enormous pain and suffering caused by a rare skin condition – Epidermolysis Bullosa (EB).

2 Aug 2023

Three doses of mRNA vaccine provide good protection for vulnerable people

Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine.

1 Aug 2023

New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody

Researchers developed potent monoclonal antibodies from a severe acute respiratory syndrome coronavirus (SARS-CoV) survivor.

1 Aug 2023

SARS-CoV-2 spike pseudovirion infection in ARPE-19 cells is a dynamin-dependent process that is primarily mediated by LDLR

Researchers reported on lentiviral pseudovirions pseudotyped with SARS-CoV-2.

1 Aug 2023

Intranasal inoculation study sheds light on nasal and systemic immune responses to SARS-CoV-2

Study reveals the events accompanying the COVID-19 infection cascade in the nasal mucosa and free circulation

1 Aug 2023

New device can detect COVID-19 in less than a minute

Benjamin Sumlin, PhD, a senior scientist at Washington University in St. Louis, blows into a device designed by researchers at the university. The device — a breath test that uses a biosensor — could become a tool for use in doctors' offices to quickly diagnose people infected with the virus that causes COVID-19.

1 Aug 2023

Antibody News and Research

Further Reading

Study reveals link between self-perceived antibody response and actual COVID-19 protection

New antibody shows promise in reversing carfentanil overdoses

Adjuvanted intranasal vaccine shows promise for long-lasting immunity to COVID-19

Understanding variations in SARS-CoV-2 evolution and clearance by immunodeficiency status

People living with HIV respond well to COVID-19 infection and vaccination

Covid cases and hospital admissions soar, leading testing expert warns of resurgence

The impact of COVID-19 vaccination and boosters on maternal SARS-CoV-2 infections and birth outcomes

Multifunctional Ga-based nanoparticles combine cancer phototherapy with immunotherapy

The association of long-term air pollution exposure with SARS-CoV-2 infection

Cryo-EM structures and functions of potent bispecific antibodies against multiple Omicron sublineages

Study finds α5 integrin as a potential therapeutic target in amyotrophic lateral sclerosis

New drug targets EMT in cancer, reducing metastasis and resistance to chemotherapy

Identifying risks and solutions: study uncovers correlates of protection against COVID-19

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

New treatment offers hope for children suffering from rare skin condition

Three doses of mRNA vaccine provide good protection for vulnerable people

New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody

SARS-CoV-2 spike pseudovirion infection in ARPE-19 cells is a dynamin-dependent process that is primarily mediated by LDLR

Intranasal inoculation study sheds light on nasal and systemic immune responses to SARS-CoV-2

New device can detect COVID-19 in less than a minute

Accelerating therapeutic antibody discovery and development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo